Advertisement


Related Videos

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement



Nov
30
Today In Oncology
Inotuzumab Ozogamicin–Based Induction in Older Patients With Philadelphia Chromosome–Negative B-Cell–Precursor ALL
Novel AI Model May Predict Nonsmokers at High Risk for Lung Cancer
Ultraprocessed Food May Heighten Risk of Head and Neck Cancer and Esophageal Adenocarcinoma
Trastuzumab Plus Gemcitabine/Cisplatin in Advanced HER2-Positive Biliary Tract Adenocarcinoma
Incidence of Breast Cancer After False-Positive Mammography
View More 
Advertisement
© 2023 HSP News Service, L.L.C.
Designed by Harborside